
BNR P/E Ratio
P/E Ratio as of Jun 13, 2025: -1.19
Average-0.8105
Median-0.6950
Minimum-1.26
Maximum-0.5800
-1.19
Past Month-0.59 (98.33%)
The P/E ratio for BNR is -1.19 as of Jun 13, 2025. This represents a increase of 45.12% compared to its 12-month average P/E ratio of -0.82. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Burning Rock Biotech P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Burning Rock Biotech’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Burning Rock Biotech to industry peers.
Burning Rock Biotech P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Burning Rock Biotech’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Burning Rock Biotech to industry peers.
BNR P/E Ratio Insights
See Burning Rock Biotech’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in BNR
Order type
Buy in
Order amount
Est. shares
0 shares
BNR P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jun 2, 2025 | $3.11 | -0.66 |
May 1, 2025 | $2.87 | -0.61 |
Apr 1, 2025 | $4.34 | -0.93 |
Mar 3, 2025 | $6.01 | -1.04 |
Feb 3, 2025 | $6.50 | -1.12 |
Jan 2, 2025 | $7.39 | -1.28 |
BNR End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -1.19 | +1.71% |
2024 | -1.17 | +23.16% |
2023 | -0.95 | -37.91% |
2022 | -1.53 | -80.95% |
2021 | -8.03 | -69.00% |
2020 | -25.90 | — |
FAQs About Burning Rock Biotech (BNR) P/E ratio
The latest P/E ratio of BNR is -1.19, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Burning Rock Biotech’s last 12-month average P/E ratio is -0.82, compared to its current P/E ratio of -1.19. This reflects a increase of 45.12%.
Burning Rock Biotech’s current P/E ratio of -1.19 is higher than its last 12-month average P/E of -0.82. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Burning Rock Biotech’s average P/E ratio over the last 3 years is -1.31. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Burning Rock Biotech’s average P/E ratio over the last 5 years is -9.71. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.